Miseq benchtop sequencer preventative maintenance
Ended Awarded Last action
- Contract number
- HHSF22301019T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $136,950
Award facts
- Contract value 100% obligated
- $136,950.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a delivery order to Illumina, Inc. for preventative maintenance services on a MiSeq benchtop sequencer. This firm fixed-price delivery order, valued at $136,950, was awarded on November 18, 2014, with an ultimate completion date of December 5, 2015, and will be performed in San Diego, California. The award carries no set-aside designation, reflecting Illumina's specialized position as the sole viable source for maintenance services on its proprietary MiSeq sequencing platform. The MiSeq is a widely-used benchtop DNA sequencing instrument employed across federal agencies for genomic research and diagnostics applications.
This delivery order likely derives from a larger indefinite delivery vehicle or blanket purchase agreement between the FDA and Illumina. Preventative maintenance contracts are critical for ensuring the continued operability of expensive laboratory equipment such as sequencing instruments, enabling the FDA to maintain its genomic analysis capabilities without incurring costly unplanned downtime or repair expenses. As a biotechnology company specializing in genetic sequencing and genomic analysis technologies, Illumina serves as a primary technology provider across multiple federal civilian and defense agencies, with a comprehensive portfolio of sequencing platforms, reagents, consumables, and associated support services.
Quick answers
Who was awarded contract HHSF22301019T?
HHSF22301019T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on November 18, 2014.
How much is contract HHSF22301019T worth?
The government has obligated $136,950 on HHSF22301019T.
Is contract HHSF22301019T an order under another contract?
Yes. HHSF22301019T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301019T competed?
The extent of competition for HHSF22301019T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award